Zimmer Reports Fourth Quarter and 2007 Financi...( WARSAW Ind. Jan. 29 /- ...),Health

WARSAW, Ind., Jan. 29 /PRNewswire-FirstCall/ --

Fourth Quarter Highlights

-- Net Sales of $1.07 billion represents an increase of 15% reported

(10% constant currency)

-- Worldwide Reconstructive Sales increased 15% reported

(10% constant currency)

-- Diluted EPS were $1.12 reported, an increase of 10% over the prior year

period, and $1.18 adjusted, an increase of 16% over the prior year

period

Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH) today reported financial results for the fourth quarter and year ended December 31, 2007. For the fourth quarter, the Company announced net sales of $1.07 billion, an increase over the prior year period of 15% reported and 10% constant currency. Diluted earnings per share for the quarter were $1.12 reported, an increase of 10%, and were $1.18 adjusted, an increase of 16%. Full year net sales were $3.9 billion, and diluted earnings per share were $3.26 reported and $4.05 adjusted, an increase of 18% adjusted over the prior year.

"We are pleased with our overall results for the fourth quarter, especially the strength of our sales across our geographic segments," said David Dvorak, Zimmer Holdings President and CEO. "Our business units around the world responded to strong underlying growth in procedures during the quarter."

During the quarter, the Company announced FDA approval of the Zimmer(R) NexGen(R) LPS-Flex Mobile Knee, only the second mobile bearing knee system to be approved for sale in the United States. The Company says that it has begun limited release of the LPS-Flex Mobile Knee and expects general availability in the U.S. in mid-2008. In addition, the Company completed its acquisitio
'/>"/>